Cystatin C, a novel cardiometabolic risk marker in women with polycystic ovary syndrome

Cystatin C and cardiovascular or all-cause mortality risk in the general population: A meta-analysis

(2015) Jian Luo et al.   CLINICA CHIMICA ACTA

Oxidative stress and cardiovascular complications in polycystic ovarian syndrome

(2015) Barkath Nisha Hyderali et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping

(2014) Donatella Caserta et al.   GYNECOLOGICAL ENDOCRINOLOGY

Premicroalbuminuria in Women with Polycystic Ovary Syndrome: A Metabolic Risk Marker

(2013) Arti Patel et al.   Endocrine Practice

High levels of cystatin C predict the metabolic syndrome: the prospective Malmö Diet and Cancer Study

(2013) M. Magnusson et al.   JOURNAL OF INTERNAL MEDICINE

Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate

(2012) Qing Xie et al.   Cardiovascular Diabetology

The association of urinary albumin excretion and metabolic complications in polycystic ovary syndrome

(2010) Gamze S. Caglar et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Predictors of urinary albumin excretion in women with polycystic ovary syndrome

(2009) Antoni J. Duleba et al.   FERTILITY AND STERILITY